ASEEL HAJAZIN: Open Payments
NPI 1457037467 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 40 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $518 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $119 |
| Janssen Biotech, Inc. | 4 | $111 |
| ABBVIE INC. | 4 | $85 |
| Daiichi Sankyo Inc. | 3 | $74 |
| BeOne Medicines USA, Inc. | 3 | $63 |
| Janssen Scientific Affairs, LLC | 1 | $53 |
| Stemline Therapeutics Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
Products named: KEYTRUDA, RYBREVANT, EPKINLY, DARZALEX, Orserdu, Enhertu, BRUKINSA, VERZENIO.
Industry payments across AL — which companies pay providers there.
